Unitek Bio Products (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -5.14%
(FY 2023)
- Profit -549.39%
(FY 2023)
- Ebitda -266.82%
(FY 2023)
- Net Worth -214.56%
(FY 2023)
- Total Assets -20.48%
(FY 2023)
About Unitek Bio Products (India)
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ramasamy Velmurugan, Ramasamy Veeraraghavan, and Dow Baik serve as directors at the Company.
- CIN/LLPIN
U01117TN2006PTC060675
- Company No.
060675
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Unitek Bio Products (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramasamy Veeraraghavan  | Whole-Time Director | 04-Aug-2006 | Current |
| Ramasamy Velmurugan | Director | 26-Jul-2006 | Current |
Dow Baik  | Director | 26-Jul-2006 | Current |
Financial Performance of Unitek Bio Products (India).
Unitek Bio Products (India) Private Limited., for the financial year ended 2023, experienced Minor drop in revenue, with a 5.14% decrease. The company also saw a substantial fall in profitability, with a 549.39% decrease in profit. The company's net worth observed a substantial decline by a decrease of 214.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unitek Bio Products (India)?
In 2023, Unitek Bio Products (India) had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Elbitec Innovations LimitedActive 23 years 6 monthsRamasamy Velmurugan and Ramasamy Veeraraghavan are mutual person
Elbitec Agro Bio Products Private LimitedActive 15 years 16 daysRamasamy Velmurugan and Ramasamy Veeraraghavan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unitek Bio Products (India)?
Unlock and access historical data on people associated with Unitek Bio Products (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unitek Bio Products (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unitek Bio Products (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
